Exelixis
EXEL
228 hedge funds and large institutions have $3.54B invested in Exelixis in 2016 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 78 increasing their positions, 86 reducing their positions, and 21 closing their positions.
150% more funds holding in top 10
Funds holding in top 10: 2 → 5 (+3)
124% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 21
82.83% more ownership
Funds ownership: 0% → 82.83% (+83%)
26% more capital invested
Capital invested by funds: $2.81B → $3.54B (+$733M)
12% more funds holding
Funds holding: 204 → 228 (+24)
2% more call options, than puts
Call options by funds: $67.5M | Put options by funds: $65.9M
9% less repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 86
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$121M |
| 2 |
MCMC
Matrix Capital Management Company
Portsmouth,
New Hampshire
|
+$105M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$54.6M |
| 4 |
Jennison Associates
New York
|
+$33.3M |
| 5 |
Two Sigma Investments
New York
|
+$29.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$79.4M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$52.9M |
| 3 |
PP
PDT Partners
New York
|
-$30.4M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$27.8M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$23.6M |
EXEL Hedge Fund Activity: Q4 2016 in Review
228 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Exelixis (EXEL) for Q4 2016, worth a combined $3.54B — up 26% from $2.81B a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new EXEL positions and 21 closed out — a net gain of 26 holders — while 78 added to existing stakes and 86 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $121M. The largest seller was OrbiMed, exiting entirely with an estimated $79.4M sold.
- 228 institutional investors held Exelixis (EXEL) as of Q4 2016, up from 204 in Q3 2016.
- Funds reported $3.54B of Exelixis stock for Q4 2016, up 26% quarter-over-quarter.
- 47 funds opened new Exelixis positions in Q4 2016 and 21 closed out, a net change of +26 holders.
- The largest Exelixis buyer in Q4 2016 was Fidelity Investments, an estimated $121M added.
- The largest Exelixis seller in Q4 2016 was OrbiMed, an estimated $79.4M sold.
Based on aggregated 13F filings for Q4 2016.